Amanote Research

Amanote Research

    RegisterSign In

CAR T Cells for Brain Tumors: Lessons Learned and Road Ahead

Immunological Reviews - United Kingdom
doi 10.1111/imr.12773
Full Text
Open PDF
Abstract

Available in full text

Categories
AllergyImmunology
Date

July 1, 2019

Authors
David AkhavanDarya AlizadehDongrui WangMichael R. WeistJennifer K. ShepphirdChristine E. Brown
Publisher

Wiley


Related search

CAR T-Cell Design: A Long Road Ahead

The Lancet Haematology
Hematology
2018English

Making CAR T Cells a Solid Option for Solid Tumors

Frontiers in Immunology
AllergyImmunology
2018English

Kyoto and the COPs: Lessons Learned and Looking Ahead

2011English

CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies

Frontiers in Immunology
AllergyImmunology
2018English

CAR T-Cell Therapy for Solid Tumors?

Cancer Discovery
Oncology
2018English

Modified T Cells Home to Brain Tumors

Cancer Discovery
Oncology
2018English

WTO Trade Monitoring Ten Years on - Lessons Learned and Challenges Ahead

SSRN Electronic Journal
2018English

Clinical Trials of Dual-Target CAR T Cells, Donor-Derived CAR T Cells, and Universal CAR T Cells for Acute Lymphoid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2019English

Collaboration of Chimeric Antigen Receptor (CAR)-expressing T Cells and Host T Cells for Optimal Elimination of Established Ovarian Tumors

OncoImmunology
OncologyAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy